← All organizations

Kymab Limited

For profitWebsite ↗

Also known as: Kymab Limited | Kymab Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 7, 2021

Acquired by Sanofi-Aventis on Jan 11, 2021

Timeline

2010s

Jun 1, 2010
Kymab Limited— Founded

2020s

Jan 11, 2021
Sanofi-Aventis— Acquired By

Drugs by trial phase (3 distinct, 5 trials)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (6)

NCT05131477Lead sponsorPhase 2Dec 7, 2021
NCT04449939Lead sponsorPhase 1Jul 7, 2020
NCT03829501Lead sponsorPhase 1/Phase 2Jan 28, 2019
NCT03829501Study directorPhase 1/Phase 2Jan 28, 2019
NCT03754309Lead sponsorPhase 2Dec 13, 2018
NCT03161288Lead sponsorPhase 1May 1, 2017

Details

Founded: Cambridge, GB Jun 1, 2010
Last known activity: Dec 7, 2021